Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis.
Incidence of multiple sclerosis in multiple racial and ethnic groups.
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis.
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Bevacizumab Diminishes Experimental Autoimmune Encephalomyelitis by Inhibiting Spinal Cord Angiogenesis and Reducing Peripheral T-Cell Responses.
Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.
Hatha Yoga and Executive Function: A Systematic Review.
Role of autophagy in the pathogenesis of multiple sclerosis.
Corrigendum.
Speech and pause characteristics in multiple sclerosis: A preliminary study of speakers with high and low neuropsychological test performance.
Distinguishing Susac's syndrome from multiple sclerosis.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Role of T cells in neuromyelitis optica.
Relationship of UV exposure to prevalence of multiple sclerosis in England.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.
A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination.
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation.
Sleep and oligodendrocyte functions.
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
[Differential diagnosis between multiple sclerosis and neurological presentations of HIV-infection: a literature review and a case report].
Lack of response to rituximab therapy in patients with neuromyelitis optica: True non-responders or insufficient treatment?
Pages
« first
‹ previous
…
222
223
224
225
226
227
228
229
230
…
next ›
last »